Pacific Biosciences Of California Net Income 2010-2024 | PACB

Pacific Biosciences Of California net income from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.

Pacific Biosciences Of California Net Income 2010-2024 | PACB

Pacific Biosciences Of California net income from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$196.3B
Intuitive Surgical (ISRG)$195.1B
Alcon (ALC)$42.4B
Edwards Lifesciences (EW)$41.6B
IQVIA Holdings (IQV)$36.6B
IDEXX Laboratories (IDXX)$34.2B
DexCom (DXCM)$28.4B
Waters (WAT)$22.2B
STERIS (STE)$21.2B
SONOVA HOLDING (SONVY)$20.8B
Hologic (HOLX)$18.3B
Fresenius Medical Care AG KGaA (FMS)$13B
Sysmex ADR (SSMXY)$12.9B
Globus Medical (GMED)$11.5B
Penumbra (PEN)$9.4B
Masimo (MASI)$9.3B
Teleflex (TFX)$8.9B
Glaukos (GKOS)$7.9B
PROCEPT BioRobotics (PRCT)$4.9B
Integer Holdings (ITGR)$4.6B
Veracyte (VCYT)$3.1B
Inari Medical (NARI)$2.9B
LivaNova (LIVN)$2.8B
TransMedics (TMDX)$2.6B
Nihon Kohden (NHNKY)$2.5B
Elekta AB (EKTAY)$2.2B
Tandem Diabetes Care (TNDM)$2B
Integra LifeSciences Holdings (IART)$1.8B
RxSight (RXST)$1.8B
Alphatec Holdings (ATEC)$1.4B